Microbial acquisition of nutrients in vivo is a fundamental aspect of infectious diseases, and is a potential target for antimicrobial therapy. Part of the innate host defense against microbial infection is nutritional restriction of access to sources of host nutrients (Abu Kwaik and Bumann, 2013; Eisenreich et al., 2013) . Despite this host nutritional restriction, there has been a long held presumption that the host cell cytosol has sufficient nutrients for any intracellular pathogen, although many bacteria fail to grow in the host cytosol if they are microinjected (Goetz et al., 2001) . However, recent studies on the two intra-vacuolar pathogens Anaplasma phagocytophilum (Niu et al., 2012) and Legionella pneumophila (Price et al., 2011) and the cytosolic pathogen Francisella tularensis (Steele et al., 2013) have clearly shown that the levels of amino acids in the host cell cytosol are below the threshold sufficient to meet the tremendous demands for carbon, nitrogen and energy to power the robust intracellular proliferation of these pathogens (Abu Kwaik and Bumann, 2013) . Therefore, these intracellular pathogens have evolved with efficient strategies to boost the levels of host amino acids to meet their demands for higher levels of carbon, nitrogen and energy sources (Abu Kwaik and Bumann, 2013; Fonseca and Swanson, 2014) . There is an emerging paradigm of specific microbial strategies that directly trigger the host cell to boost the cellular levels of essential microbial nutrients, and this paradigm has been designated as "nutritional virulence" (Abu Kwaik and Bumann, 2013) . This opinion article is focused on nutritional virulence of L. pneumophila.
In the aquatic environment, L. pneumophila proliferates within protozoa, which impact bacterial ecology and pathogenicity (Al-Quadan et al., 2012) . Upon transmission to humans, L. pneumophila proliferates in alveolar macrophages within the Legionellacontaining vacuole (LCV) that is ER-derived and evades lysosomal fusion (Figure 1) . Within both evolutionarily distant host cells, the Dot/Icm type IV secretion system of L. pneumophila injects ∼300 protein effectors (Zhu et al., 2011; Luo, 2011a ) that govern biogenesis of the LCV and modulate a myriad of cellular processes to enable intra-vacuolar proliferation (Figure 1) (Luo, 2011b; Richards et al., 2013) .
Amino acids are the main sources of carbon, nitrogen and energy for L. pneumophila, which metabolizes them through the TCA cycle (Pine et al., 1979) , but also metabolizes minor amounts of glucose in vitro using the Entner-Doudoroff pathway (Eylert et al., 2010; Price et al., 2011) . Although L. pneumophila utilizes amino acids as the main sources of carbon and energy, the pathogen is auxotrophic for seven amino acids (Cys, Met, Arg, Thr, Val, Ile, and Leu) (Eylert et al., 2010; Price et al., 2014) . Remarkably, there is a high level of synchronization in amino acids auxotrophy between L. pneumophila and its host cells, which has likely played a factor in nutritional evolution of L. pneumophila as an intra-vacuolar pathogen (Price et al., 2014) .
Interestingly, intra-vacuolar L. pneumophila up-regulates its own amino acids transporters, indicating increased demands for amino acids in the intra-vacuolar environment (Bruggemann et al., 2006; Faucher et al., 2011; Eisenreich et al., 2013) . Since the generation time of intra-vacuolar L. pneumophila is ∼40 min, this organism requires high levels of amino acids to be imported from the host cytosol into the LCV lumen (Schunder et al., 2014) . A long-held presumption has been that the host cell cytosol is rich in nutrients for invading pathogens.
However, recent studies clearly indicate that the basal levels of host cellular amino acids are below the threshold sufficient for the robust intra-vacuolar proliferation of L. pneumophila (Sauer et al., 2005; Wieland et al., 2005) To achieve that needed threshold, L. pneumophila promotes host proteasomal degradation (Price et al., 2011) of LCV-decorated polyubiquitinated proteins (Dorer et al., 2006; Price et al., 2009 Price et al., , 2011 Lomma et al., 2010) mediated by the AnkB effector.
Within human macrophages and amoeba, the AnkB translocated effector of L. pneumophila strain AA100/130b is localized to the cytosolic face of the LCV membrane through host-mediated farnesylation of its C-terminal CaaX motif (Figure 1) AlQuadan et al., 2011; Al-Quadan and Kwaik, 2011) . On the LCV membrane, AnkB interacts with the host SCF1 ubiquitin ligase (Figure 1) (Bruckert et al., 2014) . As a bona fide F-box effector (Ensminger and Isberg, 2010; Lomma et al., 2010; , AnkB triggers decoration of the LCV with Lys 48 -linked polyubiquitinated proteins that are targeted for proteasomal degradation (Figure 1) (Price et al., 2011) . The metabolomic profile of L. pneumophila-infected amoeba and human cells have shown an AnkBdependent dramatic rise in the levels of all cellular amino acids (Price et al., 2011) , and this is initiated rapidly upon bacterial attachment to the macrophage plasma membrane (Bruckert et al., 2014) . Importantly, inhibition of host proteasomal degradation abolishes intracellular proliferation of L. pneumophila strains AA100/130b and Philadelphia (Dorer et al., 2006; Price et al., 2011) . The L. pneumophila-generated surplus of host cell amino acids may explain the lack of an intracellular defect for the lysine and tryptophan auxotrophic mutants of L. pneumophila (Mintz et al., 1988; Ensminger et al., 2012) . Loss of AnkB in two independent isolates (AA100 and Paris) results in varying degrees of failure in intra-vacuolar proliferation and attenuation in the mouse model of Legionnaires' disease (AlKhodor et al., 2008; Lomma et al., 2010) . These defects for the AA100 strain are totally overcome upon supplementation of a mixture of amino acids in macrophages, amoeba and in the mouse model, similar to genetic complementation (Price et al., 2011) . Importantly, silencing of the host SCF1 ubiquitin ligase, interference with Lys 48 -linked polyubiquitination, or inhibition of the host proteasomes block intra-vacuolar proliferation of L. pneumophila, but the block is relieved upon supplementation of an excess mixture of amino acids (Price et al., 2009 (Price et al., , 2011 . Surprisingly, the intra-vacuolar proliferation defect of the ankB mutant is rescued by many individual amino acids, such as Cys, Ala or Ser, which are essential or metabolically favorable for L. pneumophila (Pine et al., 1979) . Interestingly, although Gln is the most abundant amino acid in human cells, supplementation of infected hMDMs with excess Gln alone efficiently rescues the ankB mutant (Price et al., 2011) , while Glu is a major source of carbon and energy in vitro (Pine et al., 1979) . These findings indicate that the basal levels of cellular amino acids are below the threshold sufficient for intra-vacuolar proliferation of L. pneumophila.
Remarkably, pyruvate or citrate supplementation is as effective as amino acids in rescuing the intra-vacuolar growth defect of the ankB mutant, which indicates that the LCV is capable of importing these two substrates that can feed the TCA cycle, in addition to the documented reliance of intra-vacuolar L. pneumophila on amino acids (Schunder et al., 2014) . In addition, L. pneumophila utilizes glucose through the Entner-Doudoroff pathway, which is required for proliferation within the amoeba host (Eylert et al., 2010) . During inflammation, macrophages undergo upregulation of glucose uptake and anaerobic glycolysis (Warburg-effect), which generates additional pyruvate (Eisenreich et al., 2013) , and it is likely that both glucose and pyruvate are imported by the LCV. In addition, L. pneumophila-infected macrophages exhibit a pro-inflammatory phenotype. Taken together, it is likely that a multi-prong nutritional virulence strategy is utilized by L. pneumophila to generate and retrieve a diversified portfolio of sources of carbon and energy from the host cell. The host solute carrier (SLC) family of membrane proteins (Cedernaes et al., 2011; Schioth et al., 2013) that transport various compounds, including amino acids, TCA intermediates, glucose, lipids, and drugs are likely to be involved in import of various compounds by the LCV membrane (Figure 1 ) (Wieland et al., 2005) . Future studies should unravel the host metabolites and the mechanism of their import into the LCV lumen, and subsequently by the bacterial membrane. Deciphering microbial nutrition and metabolism in vivo is essential for our understanding of hostmicrobe interaction, and nutrient retrieval strategies by intracellular pathogens are potential targets for therapy. 
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